12:00 AM
 | 
Sep 16, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Galena Biopharma completes follow-on

Galena Biopharma Inc. (NASDAQ:GALE), Portland, Ore.
Business: Cancer
Date completed: 9/13/13
Type: Follow-on
Raised: $35 million
Units: 17.5 million
Price:...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >